ECDC Annual Epidemiological report

Syphilis infections on the rise in Europe

Solna, Sweden (May 18, 2016) – New data released in ECDC’s Annual Epidemiological report show that since 2010, the overall syphilis rates have been going up across Europe, particularly among men. In 2014, the reported syphilis numbers were six times higher in men than in women. Almost two-thirds (63%) of the syphilis cases reported with information on transmission category were recorded in men who have sex with men (MSM).

In 2014, 24 541 syphilis cases were reported in 29 EU/EEA Member States (no data from Austria and Liechtenstein), resulting in an overall rate of 5.1 per 100 000 population. The majority of infections were reported in people older than 25 years while young people between 15 and 24 accounted for only 13% of cases.

Between 2010 and 2014, many countries, particularly in western Europe, saw a sharp upsurge in the number of reported syphilis infections, with increases of over 50% in Belgium, France, Germany, Iceland, Ireland, Luxembourg, Malta, Norway, Portugal and the United Kingdom. While the data show a marked increase of syphilis cases among men across Europe, cases among women have decreased.

Largest increase among those aged 45 and over. Between 2005 and 2014, 208 134 cases of syphilis were reported in 30 countries. Over this decade, the proportion of cases among age groups below 35 years went down, while they went up among those aged 35 years or over. The largest increases were seen in those aged 45 years or over: their proportion rose from 18% to 30%.

The overall increasing trend of syphilis in many EU/EEA countries – driven by infections among MSM — is likely linked to changes in sexual behaviour in this group. More complete reporting and improved case detection through, for example, more testing among HIV-positive MSM, as recommended in current HIV management guidelines, have also contributed to this trend.

Promoting safe sexual behaviour and increasing testing rates among risk groups through targeted prevention campaigns is essential to prevent cases and reduce the risk of the complications of late stages of syphilis infection through earlier diagnosis. Approaches that use social media and dating apps for prevention campaigns may be considered in addition to traditional approaches.


More information


European Centre for Diseas e Prevention and Control (ECDC), 18.05.2016 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Wie ein Schmerz den anderen unterdrückt
Opioidtherapien im palliativen Praxisalltag: Retardierte Analgetika zeigen Vorteile
Krankenhäuser und Praxen müssen sich bei der Schmerztherapie nach Operationen…
Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle

DIABETES

Suliqua®: Eine sinnvolle Option, wenn die BOT zur Blutzuckerkontrolle nicht…
„Körperstolz“: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Bestmögliche Versorgungssicherheit bei der Krebstherapie mit CAR-T-Zellen
Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Neue Darreichungsform zur Antiemese bei Chemotherapie: Akynzeo® ist ab sofort…

MULTIPLE SKLEROSE

Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei aktiver…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…